Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Jun 23, 2023
AMGN Experiences a Positive Boost of +4.43% with Tickeron's Automated Trading

AMGN Experiences a Positive Boost of +4.43% with Tickeron's Automated Trading

The Swing trader: Top High-Volatility Stocks v.2 (TA) AI trading robot has demonstrated its prowess once again, delivering impressive gains of +4.43% while trading AMGN (Amgen) over the previous week. This article will delve into the recent earnings results of AMGN and analyze the potential implications for traders.

Analyzing Earnings Results:

AMGN's latest earnings report, released on April 27, showcased the company's strong performance, surpassing expectations with earnings per share (EPS) of $3.98 compared to the estimated $3.82. This positive surprise indicates the company's ability to generate robust profits and highlights its potential for growth.

Market Capitalization:

With 41.92K shares outstanding, AMGN's current market capitalization stands at an impressive $122.14 billion. This figure reflects the market's valuation of the company based on its outstanding shares and demonstrates AMGN's substantial presence in the pharmaceutical industry.

Technical Analysis:

Aside from the encouraging earnings results, technical indicators also suggest a potential shift in AMGN's stock trend. On June 2, 2023, the Relative Strength Index (RSI) Oscillator for AMGN moved out of oversold territory. This development indicates that the stock may be transitioning from a downward trend to an upward trend, presenting an opportunity for traders.

To further analyze this shift, the A.I.dvisor examined 32 instances when the RSI indicator left oversold territory. In 20 out of those 32 cases, the stock price moved higher. This statistical observation implies that the probability of AMGN moving higher after leaving oversold territory is approximately 62%.

Implications for Traders:

Considering the positive earnings report, with AMGN surpassing EPS estimates, combined with the technical analysis indicating a potential shift in the stock's trend, traders may view this as an opportune moment. The positive earnings results and the RSI indicator's movement out of oversold territory provide a favorable backdrop for considering investment in AMGN, either through buying the stock or call options.

Related Ticker: AMGN

AMGN's Indicator enters downward trend

The Aroon Indicator for AMGN entered a downward trend on April 16, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 191 similar instances where the Aroon Indicator formed such a pattern. In of the 191 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where AMGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on April 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMGN as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AMGN moved below its 50-day moving average on March 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMGN crossed bearishly below the 50-day moving average on March 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMGN's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on April 09, 2026. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.739) is normal, around the industry mean (9.095). P/E Ratio (24.553) is within average values for comparable stocks, (21.491). Projected Growth (PEG Ratio) (2.341) is also within normal values, averaging (3.112). Dividend Yield (0.028) settles around the average of (0.026) among similar stocks. P/S Ratio (5.152) is also within normal values, averaging (3.858).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NYSE:AZN), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 104.57B. The market cap for tickers in the group ranges from 72.83K to 807.59B. LLY holds the highest valuation in this group at 807.59B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -0%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 6%. OGN experienced the highest price growth at 35%, while MDCX experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was 14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 29
P/E Growth Rating: 66
Price Growth Rating: 54
SMR Rating: 55
Profit Risk Rating: 73
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AMGN showed earnings on February 03, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interact to see
Advertisement
As a financial analyst, writer, and AI specialist at Tickeron, I analyze NWBO (Northwest Biotherapeutics, Inc.) through proprietary AI models, revealing strong bullish signals. On September 30, 2025, NWBO broke its lower Bollinger Band, historically preceding rises in 33 of 36 cases (90% probability) within the next month.
Tickeron, a pioneer in AI-driven trading solutions, today unveiled groundbreaking performance results from its advanced AI Trading Agents, showcasing annualized returns as high as +206% in ultra-short 5-minute machine learning cycles.
#artificial_intelligence
Leading AI-Powered Trading Solutions Provider: As a financial analyst, writer, and artificial intelligence specialist, this press release provides a comprehensive forecast, quote, news, and analysis for Micron Technology (MU) stock, leveraging advanced AI insights from Tickeron.com.
#trading#artificial_intelligence
Tickeron, a pioneer in AI-powered trading solutions, today releases its comprehensive forecast, quote, news, and analysis for Alibaba Group Holding Limited (BABA) stock. Leveraging advanced Financial Learning Models (FLMs) and Machine Learning Models (MLMs), Tickeron’s AI tools highlight BABA’s robust performance, including a 54.30% year-to-date gain and a current +5.94% uptrend over three consecutive days.
#artificial_intelligence
Tickeron, a pioneer in AI-powered financial tools, today announced the release of enhanced AI Trading Agents utilizing groundbreaking 5-minute and 15-minute Machine Learning (ML) time frames.
#artificial_intelligence
Tickeron, a pioneer in AI-driven trading solutions, today announced exceptional performance from its AI Trading Agent specialized in NVIDIA Corporation (NVDA) stock. Leveraging advanced 15-minute and weekly data analysis, the agent achieved an impressive annualized return of 375.27%, highlighted by closing 9 out of 9 trades profitably over the past week.
A Roth IRA is widely regarded as one of the most powerful retirement savings tools available. Since contributions are made with after-tax income, all qualified withdrawals — including both contributions and investment gains after age 59½ — are entirely tax-free, provided you follow the account’s guidelines.
#trading
Tickeron, a leader in AI-powered financial analytics, proudly introduces its upgraded Pattern Search Engine (PSE) — an intelligent screener designed to detect chart patterns across stocks, ETFs, penny stocks, crypto, and forex with ease and precision.
#trading#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, announces impressive results from its W.X Trading Robot, an AI Trading Agent specializing in long and short positions on the W.USD cryptocurrency ticker with a 60-minute timeframe.
Tickeron, a leader in AI-powered financial innovation, has reported exceptional performance from its AI Trading Bots, achieving annualized returns of up to 204% across multiple trading pairs.
As someone intrigued by stock trading but often buried under charts and endless data, I decided to test Tickeron’s AI Stock Screener and its integrated Time Machine backtesting feature.
#artificial_intelligence
Tickeron. a leader in AI-driven trading technology, has unveiled record-setting results from its newest generation of AI Trading Agents. Powered by proprietary Financial Learning Models (FLMs) and advanced Machine Learning Models (MLMs), these systems have achieved annualized returns of up to +172%, establishing a new standard for excellence in algorithmic trading performance.
After three months of using Tickeron’s AI-powered pattern recognition tool, I discovered how automation, real-time alerts, and data-driven signals can completely transform trading. From faster decisions to smarter risk management, AI made my trading more efficient, confident, and profitable.
Tickeron, a global innovator in AI-powered financial technology, has launched its groundbreaking AI Trend Prediction Engine (TPE) — a state-of-the-art platform that provides unmatched precision in short-term stock trend forecasting.
#artificial_intelligence
In the fast-paced world of financial markets, where milliseconds can mean millions, artificial intelligence has emerged as the ultimate game-changer.
Tickeron, a global innovator in AI-powered trading solutions, has announced outstanding results from its 5-minute AI Trading Agent focused on HUBB, AVGO, ITA, and QQQ. In just 36 days, the agent achieved a 70% win rate, generating $3,439 in closed trade profits and a remarkable +40% annualized return.
SoFi Technologies, Inc. has staged one of 2025’s most remarkable rallies, climbing 248.8% from its April 7 low of $8.60 to close at $30.00 on October 27.
#artificial_intelligence